BIOTRONIK SE & Co. KG, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, today announced the first implantations of the Lumax DX System, a ...

BIOTRONIK has announced the Food and Drug Administration (FDA) has granted final approval for the BIOTRONIK Lumax 740 DX System. This novel device is a first-in-class implantable cardiac defibrillator ...

Biotronik, a leading manufacturer of cardiovascular medical technology that offers the world's largest portfolio of ProMRI cardiac implants, has launched its Iperia 7 VR-T DX ProMRI single-chamber ...

April 25, 2012 (Denver, Colorado) — A new study on the use of dual- and single-chamber implantable cardioverter defibrillators (ICDs) in patients without a pacemaker indication highlights the critical ...

The introduction of dual-chamber pacing in current ICD has facilitated and improved the treatment of ICD recipients with concomitant standard dual-chamber pacemaker indication. Whether dual-chamber ...

Editor’s Note: The following guest post is published with the permission of its author, Edward J. Schloss, MD, (Twitter ID @EJSMD) the medical director of cardiac electrophysiology at Christ Hospital ...